Literature DB >> 1672269

Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex.

H S Howe1, A K So, J Farrant, A D Webster.   

Abstract

Common variable immunodeficiency (CVI) is a heterogeneous condition characterized by arrest in B cell differentiation. A high frequency of null alleles of the C4 gene has been reported in patients with this disorder. We investigated the restriction fragment length polymorphisms (RFLP) of the MHC class II genes HLA-DRB, DQA, and DQB, the class III gene C4 and the tumour necrosis factor-alpha) (TNF-alpha) gene in 40 Caucasian patients. The results showed an increase in HLA-DR3 in patients (40% vs 30.5%), but, more significantly, there was a striking increase in the number of CVI patients who carried a deletion of the C4A gene (46% vs 25%). In both patients and controls there was strong allelic association between HLA-DR3 and C4A deletion, and HLA-DR3 and TNF-alpha. Our results suggest that genes present on an extended haplotype containing these three polymorphisms contribute to genetic susceptibility to CVI.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672269      PMCID: PMC1535318          DOI: 10.1111/j.1365-2249.1991.tb05648.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Autoimmunity in the relatives of patients with immunodeficiency diseases.

Authors:  J M Friedman; P J Fialkow; S D Davis; H D Ochs; R J Wedgwood
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases.

Authors:  L Fugger; N Morling; L P Ryder; J Georgsen; B K Jakobsen; A Svejgaard; V Andersen; P Oxholm; F Karup Pedersen; J Friis
Journal:  Tissue Antigens       Date:  1989-07

3.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Authors:  F M Schaffer; J Palermos; Z B Zhu; B O Barger; M D Cooper; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Role of retroviruses in acquired hypogammaglobulinaemia.

Authors:  G P Spickett; M Millrain; R Beattie; M North; J Griffiths; S Patterson; A D Webster
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  A new cluster of genes within the human major histocompatibility complex.

Authors:  T Spies; G Blanck; M Bresnahan; J Sands; J L Strominger
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

6.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.

Authors:  P M Schneider; M C Carroll; C A Alper; C Rittner; A S Whitehead; E J Yunis; H R Colten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

7.  Human major histocompatibility complex contains genes for the major heat shock protein HSP70.

Authors:  C A Sargent; I Dunham; J Trowsdale; R D Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

8.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2.

Authors:  A Bryant; N C Calver; E Toubi; A D Webster; J Farrant
Journal:  Clin Immunol Immunopathol       Date:  1990-08

9.  Immunoglobulin A deficiency: genetic studies.

Authors:  K Oen; R E Petty; M L Schroeder
Journal:  Tissue Antigens       Date:  1982-03

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  7 in total

1.  Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes.

Authors:  H W Schroeder; Z B Zhu; R E March; R D Campbell; S M Berney; S A Nedospasov; R L Turetskaya; T P Atkinson; R C Go; M D Cooper; J E Volanakis
Journal:  Mol Med       Date:  1998-02       Impact factor: 6.354

Review 2.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

3.  HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID).

Authors:  E G De La Concha; M Fernandez-Arquero; A Martinez; F Vidal; P Vigil; L Conejero; M C Garcia-Rodriguez; G Fontan
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Autoimmune manifestations in common variable immunodeficiency.

Authors:  Stavroula Giannouli; Dimitra Anagnostou; Fotini Soliotis; Michalis Voulgarelis
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

5.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency.

Authors:  O Olerup; C I Smith; J Björkander; L Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Variable immunodeficiency score upfront analytical link (VISUAL), a proposal for combined prognostic score at diagnosis of common variable immunodeficiency.

Authors:  Kissy Guevara-Hoyer; Adolfo Jiménez-Huete; Julia Vasconcelos; Esmeralda Neves; Silvia Sánchez-Ramón
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.